About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Anti COVID-19 Convalescent Plasma Therapy

NCT04345679·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Eszter Fodor, medical doctor
CONTACT
+36306640494 eszter.fodor@orthosera.com
Zsombor Lacza, MD, PhD
CONTACT
+36305249554 zsombor.lacza@orthosera.com

Lead

Orthosera Kft.

With

Semmelweis University
University of Pecs
Hungarian National Blood Service
Humán Bioplazma Kft - Kedrion

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

age : \>18 and \<60 years
body weight : \>50 kg
confirmed previous SARS CoV-2 infection
2 negative SARS CoV-2 test result
written informed consent
neutralizing antibody titer min. 1 : 120
age : \>18 years
admitted to hospital due to SARS CoV-2 infection
written informed consent

You may not be if

age : \<18 or \>60 years
female subjects who are pregnant
HIV1,2 hepatitis B,C or syphilis infection
to minimize the transfusional side effects our aim is to include mostly male donors.
age : \<18 years
female subjects who are pregnant or breastfeeding
patients with prior allergic reaction to transfusion
patients who received in the past 30 days immunoglobulin therapy

The record

StatusUnknown

PhaseEarly phase 1

Taking part20

StartedApr 2020

UpdatedFeb 25, 2021

Conditions

Where1

Semmelweis University's Department of Pulmonology
Budapest, Hungary

Clareo Health | Anti COVID-19 Convalescent Plasma Therapy